TREATMENT OF HCV WITH SUBTHERAPEUTIC DOSES OF RIBAVIRIN

摘要

The invention provides combinations of ribavirin with other antiviral drugs, wherein what would normally be a sub-therapeutic dose of ribavirin is rendered effective by a synergistic interaction with one or more other antiviral agents. The invention also provides combinations of ribavirin with other antiviral drugs, wherein what would normally be a sub-therapeutic dose of the other drug is rendered effective by a synergistic interaction with ribavirin.